An FDA panel is expected to decide Wednesday if the diabetes drug Avandia should stay on the market.
Government experts are trying to determine if the once popular drug can increase the risk of heart attack.
The panel could recommend putting more warning labels on Avandia or pulling it.
The FDA usually follows recommendations from the advisory committee.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.